You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (124)

Journals (0)

1-10 of 124 results for multicenter phase II study

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

Open access

Research article

First published 2013

Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

Kurume Surgical and Clinical Oncology Group

Clinical Medicine Insights: Oncology

Select article: Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD

Open access

Research article

First published 2022

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD

Dong Won Baek, Hee Jeong Cho, Ju-Hyung Kim [...]

Cell Transplantation

Select article: Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)

Retricted access

Research article

First published 2024-12

Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)

Amelia Barcellini, Silvia Molinelli, Alessandro Vanoli [...]

Tumori Journal

Select article: Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter,randomized,double-blind,placebo-controlled,phase II study

Open access

Research article

First published 2024

Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter,randomized,double-blind,placebo-controlled,phase II study

Shukui Qin, Yusheng Wang, Jun Yao [...]

Therapeutic Advances in Medical Oncology

Select article: A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma

Open access

Research article

First published 2018

A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma

Nam Bui, Nikhil Kamat, Vinod Ravi [...]

Rare Tumors

Select article: A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy

Open access

Research article

First published 2022

A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy

Guangxin Peng, Guangsheng He, Hong Chang [...]

Therapeutic Advances in Hematology

Select article: Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter,randomized,double-blind,phase II study

Open access

Research article

First published 2022

Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter,randomized,double-blind,phase II study

Honghu Tang, Beibei Cui, Yiyu Chen [...]

Therapeutic Advances in Musculoskeletal Disease

Select article: Subcutaneous Recombinant Interleukin-2 and a -Interferon in Patients with Advanced Renal Cell Carcinoma: Results of a Multicenter Phase II Study

Retricted access

Research article

First published 1993-12

Subcutaneous Recombinant Interleukin-2 and a -Interferon in Patients with Advanced Renal Cell Carcinoma: Results of a Multicenter Phase II Study

Jens Atzpodien, Hartmut Kirchner, Peter de Mulder [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Combined Epirubicin and Interleukin-2 Regimen in the Treatment of Malignant Mesothelioma: A Multicenter Phase II Study of the Italian Group on Rare Tumors

Retricted access

Research article

First published 1998-9

Combined Epirubicin and Interleukin-2 Regimen in the Treatment of Malignant Mesothelioma: A Multicenter Phase II Study of the Italian Group on Rare Tumors

Sergio Bretti, Alfredo Berruti, Luigi Dogliotti [...]

Tumori Journal

Select article: Weekly Docetaxel and Gemcitabine following Docetaxel plus Epirubicin or Vinorelbine as First-Line Treatment of Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Retricted access

Research article

First published 2006-1

Weekly Docetaxel and Gemcitabine following Docetaxel plus Epirubicin or Vinorelbine as First-Line Treatment of Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Alberto Riccardi, Silvia Brugnatelli, Marco Danova [...]

Tumori Journal

1
2
3
•••
13
10 / page

Article type

Publication date

Subjects

Access